Prostatectomy

Serum Vitamin D Levels Predict Adverse Pathology at Prostatectomy

By

Both insufficiency and deficiency of serum vitamin D correlated with an increased risk of unfavorable pathology in men undergoing radical prostatectomy for prostate cancer.

Racial Differences in Outcomes and Costs of Care in Older Men with Prostate Cancer

Racial Differences in Outcomes and Costs of Care in Older Men with Prostate Cancer

By

Older black men with localized prostate cancer were more likely to have poorer quality care, incur higher costs, and have worse postoperative outcomes than white men. However, that did not translate to worse overall or cancer-specific survival.

Low-risk prostate cancer cases often upgraded at prostatectomy

Low-risk prostate cancer cases often upgraded at prostatectomy

A recent study indicates a high rate of clinical upgrading at prostatectomy, based on over ten thousand patients reviewed.

Patients with detectable PSA after prostatectomy should receive more aggressive radiation therapy

Patients with detectable PSA after prostatectomy should receive more aggressive radiation therapy

By

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.

Considerable practice variation among surgeons in selecting patients for radical prostatectomy

Considerable practice variation among surgeons in selecting patients for radical prostatectomy

Variation was observed at a high-volume center when surgeons selected patients with low-risk prostate cancer to undergo radical prostatectomy, according to a study.

PDE-5 inhibitors linked to prostate cancer biochemical recurrence

PDE-5 inhibitors linked to prostate cancer biochemical recurrence

Phosphodiesterase type 5 inhibitors up the risk of biochemical recurrence after radical prostatectomy, according to a recent study.

ASCO endorses guideline for adjuvant and salvage radiotherapy after prostatectomy

ASCO endorses guideline for adjuvant and salvage radiotherapy after prostatectomy

The endorsed guideline outlines use of adjuvant and salvage radiotherapy after surgery for prostate cancer.

Overdetection of PSA recurrence after radical prostatectomy more likely in older patients

Overdetection of PSA recurrence after radical prostatectomy more likely in older patients

For some men, prostate cancer recurrence may be overdetected, especially in those aged over 70.

Informed consent plays large in prostatectomy litigation

Informed consent plays large in prostatectomy litigation

Claims of not receiving proper informed consent and clinical performance are the main issues that arise in radical prostatectomy malpractice lawsuits.

Prostatectomy lowers early prostate cancer mortality

Prostatectomy lowers early prostate cancer mortality

Risk of long-term mortality for those that undergo surgical treatment is lower, compared with men who choose watchful waiting.

Robot-assisted prostatectomy yields improved surgical margins

Robot-assisted prostatectomy yields improved surgical margins

Robot-assisted radical prostatectomy (RARP) is associated with improved surgical margin status compared with open radical prostatectomy (ORP) for intermediate- and high-risk disease.

ASTRO/AUA co-issue guideline on radiation for prostate cancer

By

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) have set forth several recommendations on radiation therapy after prostatectomy.

Prostate cancer recurrence not reduced by soy supplement

By

Among men who had undergone radical prostatectomy, daily consumption of a soy protein supplement did not reduce or delay development of biochemical recurrence of prostate cancer

Soy supplement doesn't reduce prostate cancer recurrence

Soy supplement doesn't reduce prostate cancer recurrence

No reduction in biochemical recurrence within two years of radical prostatectomy, despite daily soy protein ingestion.

African-Americans show poorer outcomes for low-risk prostate cancer

African-Americans show poorer outcomes for low-risk prostate cancer

Worse outcomes are seen for African-American men with low-risk prostate cancer who undergo prostatectomy, according to a study published online in the Journal of Clinical Oncology.

 Men with comparable prostate cancer show similar outcomes despite prostatectomy timing

Men with comparable prostate cancer show similar outcomes despite prostatectomy timing

Finding in men with similar prostate conditions undergoing watchful waiting versus immediate surgery proved to be similar.

Outcomes similar for newer and older radiotherapy after prostatectomy

By

A recent study uncovered no significant differences in morbidity or recurrence rates between men with prostate cancer who underwent conformal radiotherapy (CRT) or those receiving newer intensity-modulated radiotherapy (IMRT) following prostatectomy.

IMRT offers no significant benefit over CRT following prostatectomy

IMRT offers no significant benefit over CRT following prostatectomy

No significant difference in morbidity, cancer control for men treated post-prostatectomy using Intensity-modulated radiotherapy (IMRT) over conformal radiotherapy (CRT).

Surgeon Variation Affects QoL After Prostatectomy

Surgeon Variation Affects QoL After Prostatectomy

Significant associations seen in men's urinary and sexual function based on surgeon performing radical prostatectomy.

25-year survival after prostate radiation matches prostatectomy

25-year survival after prostate radiation matches prostatectomy

By

Late recurrence of prostate cancer is rare if PSA is less than 0.2 ng/mL, the surgical PSA definition of cancer control, 15 years after treatment with radiation therapy.

Analysis explores best use of radical prostatectomy vs watchful waiting

Researchers assessed why two studies comparing prostatectomy with watchful waiting had conflicting findings in absolute mortality difference.

Study results support patient concerns about a controversial side effect of therapy

Study results support patient concerns about a controversial side effect of therapy

By

A posttreatment assessment of men who underwent treatment for prostate cancer revealed a side effect that has a significant impact on patients.

Radiotherapy after prostatectomy has long-term benefits

Administering radiotherapy after prostatectomy helped nearly two-thirds of users in a recent study remain free of prostate cancer after 10 years.

Watchful waiting offers more quality years than prostatectomy

Compared with prostatectomy, surveillance will likely reduce prostate cancer-specific survival only slightly and greatly enhance quality of life.

Surveillance for low-risk prostate cancer examined

Surveillance for low-risk prostate cancer examined

Simulation model compares long-term effect of active surveillance versus immediate prostatectomy.

Lower Prostate Cancer-Specific Death With Anticoagulant Use

Lower Prostate Cancer-Specific Death With Anticoagulant Use

Aspirin primarily contributes to reduction for localized cancer treated with prostatectomy, radiotherapy.

Prostatectomy did not notably reduce mortality in study

Radical prostatectomy did not significantly reduce all-cause or prostate cancer mortality compared with observation in men with localized disease.

Imaging May Spare Nerves in Prostate Cancer Surgery

Imaging May Spare Nerves in Prostate Cancer Surgery

Preoperative MRI led to a change in surgical plan in 27 percent of robot-assisted prostatectomies.

Radical prostatectomy for locally advanced prostate cancer shows long-term success

The results of a large study indicate that radical prostatectomy offers durable cancer control and survival rates 20 years following surgery for men with locally advanced prostate cancer.

Minimally invasive radical prostatectomy

The popularity of minimally invasive radical prostatectomy (MIRP) has risen despite lack of data on outcomes and higher costs compared with open retropubic radical prostatectomy (RRP), say US researchers

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs